Persei vivarium (Digital Health)

What Persei vivarium (Digital Health) does

Persei vivarium is a Madrid-based Digital Health company founded in 2015 that builds and operates a portfolio of certified platforms and digital therapeutics on its proprietary Perseed® technology stack. Its products include Caaring® for patient follow-up and real-world data capture, onQos® for oncology outcomes management, ClinicaaL® for pathology management, ReseaArch® as an eClinical ecosystem, and Clitinerary® for market research, supported by disease-specific deployments such as the ENEIDA IBD registry (100+ centers, 88,000+ patients, 70+ peer-reviewed publications) and joint solutions with Hospital Clínic de Barcelona (Endoclinic, Colonclinic). The company is heavily certified for healthcare-grade deployment, holding ISO/IEC 27001, ISO 13485, ISO 33000, ENS High Level, HDS, GDPR, 21 CFR Part 11, and Class I medical device certifications, and it operates a high-availability multitier architecture across three data centers.

The company generates revenue primarily through enterprise B2B sales of its platforms and digital therapeutics to hospitals, healthcare systems, pharmaceutical and medical device companies, and CROs, with multi-year subscription/licensing contracts and select co-development arrangements. Customer segments span hospitals and healthcare systems (clinical research, pathology management, remote monitoring), pharma and medical device companies (DTx co-development, Real-World Data generation), and government health authorities. Distribution is direct enterprise field sales supplemented by industry events (SEDISA, ECCO, MAD e-Health, South Summit, BIND 4.0), and the company maintains active content marketing and social media channels. It was initially financed by Avalmadrid and later by ENISA, Big Sur Ventures, and Kereon Partners, and in September 2025 joined Zelenza Group to accelerate growth and broaden enterprise reach.

Name

Persei vivarium (Digital Health)

Legal name

Persei vivarium, S.L.

Website

https://perseivivarium.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Persei vivarium is a Madrid-based Digital Health company founded in 2015 that builds certified patient follow-up, oncology, eClinical, and pathology management platforms on its proprietary Perseed® technology, serving hospitals, pharma, and medical device companies across Spain and selected international markets.

Ownership category

akta.pro rank

Product category

Digital Health Software Platforms

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industries

Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF), Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Digital health platforms
• Clinical research software
• Digital therapeutics
• Patient monitoring systems
• Real-world evidence

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Digital Health Platform/SaaS Licensing: The company licenses its Digital Health platforms (Caaring®, onQos®, ClinicaaL®, ReseaArch®, Clitinerary®) to healthcare organizations, hospitals, and pharmaceutical companies. These platforms are offered as ongoing services suggesting subscription or licensing revenue.
2. Digital Therapeutics (DTx) Solutions: Persei vivarium creates customized Digital Therapeutics for pharmaceutical companies, medical device companies, hospitals, and clinics. These are evidence-based therapeutic interventions delivered through software. Revenue likely comes from development fees, licensing, or per-patient usage fees.
3. Clinical Research Services: Through ReseaArch®, the company provides eClinical ecosystem services for clinical research initiatives, offering data management tools and Digital Health infrastructure. This may include professional services for trial setup and ongoing support.
4. Pharma & Medical Device Company Partnerships: DTx solutions offered to pharma and medical device companies to complement their therapies, improve treatment adherence, offer better patient experience, and obtain Real-World Data evidence. This suggests revenue from co-development partnerships or licensing agreements with pharmaceutical companies.
5. Healthcare Institution Platforms: Platforms like ClinicaaL® for pathology management and Caaring® for patient follow-up are sold/licensed to hospitals and healthcare institutions, suggesting institutional sales revenue.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

Persei vivarium develops and licenses Digital Health ecosystems built on its proprietary Perseed® platform, covering clinical research (ReseaArch®), pathologies management (ClinicaaL®), patient follow-up and real-world data capture (Caaring®), oncology outcomes (onQos®), market research (Clitinerary®), and customized Digital Therapeutics for pharmaceutical and medical device partners. The company deploys these solutions as cloud-based SaaS platforms with high-availability, multitier architecture supporting clinical practice management, patient itinerary optimization, remote patient monitoring, and real-world evidence generation.

Product overview

Persei vivarium offers a portfolio of interconnected Digital Health platforms built on its Perseed® technology. The core product ecosystem includes Caaring® for patient follow-up and real-world data capture, onQos® for oncology outcomes management, ReseaArch® for clinical research (eClinical), ClinicaaL® for pathologies management, and Clitinerary® for market research. Supporting projects include Endoclinic and Colonclinic (developed with Hospital Clínic de Barcelona), and the ENEIDA IBD registry. The company also develops Digital Therapeutics (DTx) solutions. The architecture is multitier with high availability, deployed across three data centers, enabling daily clinical practice management, clinical research, patient itinerary optimization, and remote patient monitoring.

Differentiator

Problem solved

Functional benefit

Brands

• Caaring®: Solution for patient follow-up, real life data capture and patient support programs, to reduce visits, maintain therapeutic adherence, generate evidences about real life data and improve the quality of life of patients.
• onQos®
• ReseaArch®
• ClinicaaL®
• Clitinerary®
• Perseed®

Products and services

• Caaring®

Quantifiable outcome

• 28% of patients experience non-adherence to oral cancer treatments - Persei vivarium's digital solutions aim to improve this rate
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature12 records

Partnerships

13 partnerships are on record, tiered core, key and supporting.

• Zelenza GroupcoreStrategic or Co-development Partner · 1 September 2025Persei vivarium joined Zelenza Group in September 2025, a leading Spanish technology group in Managed Services, Engineering, and Security. This strategic move is designed to enhance Persei vivarium's growth and development capabilities.
• FAES FARMAkeyStrategic or Co-development Partner · 1 September 2019Collaboration on allergy project as part of BIND 4.0 (Basque Industry 4.0 Accelerator Program). FAES FARMA is a pharmaceutical company. The project aims to improve healthcare process and services for allergy patients and provide research opportunities.
• QuirónsaludkeyStrategic or Co-development Partner · 1 September 2019Collaboration on allergy project as part of BIND 4.0. Quirónsalud is a major hospital group in Spain. The project aims to improve healthcare process for allergy patients through digital health solutions.
• OSASEN (biosensors for healthcare)supportingTechnology or Integration · 1 September 2019Collaboration on allergy project as part of BIND 4.0. OSASEN provides biosensors for healthcare. The project integrates Persei vivarium's digital health solutions with biosensor technology for comprehensive allergy patient management.
• Mestrelab Research S.L.supportingStrategic or Co-development Partner · 1 January 2019Mestrelab and Persei vivarium have a strategic partnership as investors and strategic partners. Mestrelab develops software solutions for pharmaceutical, biotechnology, and chemical industries. Persei vivarium congratulated Mestrelab on their strategic partnership with Bruker Corporation.
• Lovexair FoundationsupportingStrategic or Co-development Partner · 1 June 2017Collaboration agreement in chronic respiratory disease. Lovexair is a foundation promoting understanding of pulmonary disease prevention and monitoring. The partnership supports the HappyAir initiative for respiratory disease patients through collaborating pharmacies.
• BDVA (Big Data Value Association)supportingStrategic or Co-development Partner · 1 April 2017Initial contact with Big Data Value Association to explore collaboration around Big Data. BDVA is a not-for-profit organization that is the private counterpart to the EU Commission for the BDV Public-Private Partnership program. BDVA aims to boost European Big Data Value research and identify applications where big data can create biggest impact, including healthcare.
• SOMEEC (Mexican Society of Electrophysiology and Cardiac Stimulation)supportingStrategic or Co-development Partner · 1 March 2017Visit by SOMEEC board to Persei vivarium Madrid office to explore collaboration opportunities. SOMEEC is a leading medical association for electrophysiology specialists. Meeting explored current and future projects and potential collaboration areas.
• Dialibre ClinicsupportingStrategic or Co-development Partner · 1 May 2016Formalized cooperation in diabetes management. Dialibre is a Madrid clinic specializing in diabetes and nutrition for children and youth, offering in-person and virtual medical and psychological services. The partnership supports diabetes care through digital health solutions.
• DiabetesCEROsupportingStrategic or Co-development Partner · 1 January 2016Support for the DiabetesCERO movement, an initiative formed by doctors, nurses, mathematicians, and other professionals working to support diabetes research in Spain. Persei vivarium and Dialibre medical clinic support this movement.
• GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis)coreStrategic or Co-development PartnerPersei vivarium provides technology and services for the ENEIDA national registry (Estudio Nacional en Enfermedad Inflamatoria Intestinal sobre Determinantes Genéticos y Ambientales), a national prospective registry for Inflammatory Bowel Disease. The registry includes data from more than 100 centers and over 88,000 patients, and has generated 70+ peer-reviewed scientific publications. This is a flagship collaboration demonstrating the company's capability in large-scale Real-World Evidence generation.
• Hospital Clínic de BarcelonacoreStrategic or Co-development PartnerCollaboration on Endoclinic (platform for managing digestive endoscopies and clinical research) and Colonclinic (application for colonoscopy patients). This hospital partnership demonstrates Persei vivarium's ability to co-develop solutions with prestigious healthcare institutions.
• Effice Research (CRO)keyStrategic or Co-development PartnerCollaboration with Effice Research, a Contract Research Organization (CRO), on research projects. Effice Research works with Persei vivarium to integrate Digital Health solutions enabling real-time outcome monitoring and improved patient experience in clinical trials.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Castor EDC: Amsterdam-based eClinical/EDC platform offering clinical trial data capture tools, comparable to Persei vivarium's ReseaArch® ecosystem. Both target clinical research sponsors and CROs with mid-market and academic-led studies, and both emphasize regulatory compliance (21 CFR Part 11) and ease of use for non-enterprise customers.
• OpenClinica: Open-source eClinical platform providing EDC and clinical data management for academic and commercial trials. Comparable to Persei vivarium's ReseaArch® in targeting clinical research operations with an integrated data management approach, including support for decentralized and registry-style studies.
• Voluntis: France-based Digital Therapeutics company developing companion DTx for oncology, diabetes, and respiratory conditions, partnered with major pharma. Highly comparable to Persei vivarium's DTx portfolio targeting similar therapeutic areas with regulatory-cleared software and pharma licensing models.
• Kaia Health: Germany-based DTx company focused on musculoskeletal pain, COPD, and chronic condition management via mobile applications. Comparable to Persei vivarium's Caaring® and condition-specific DTx programs in targeting chronic disease self-management, treatment adherence, and outcomes improvement.
• Biofourmis: US/Singapore-based RPM and DTx platform combining wearable biosensors, AI analytics, and condition-specific care pathways for cardiology, oncology, and chronic disease. Comparable to Persei vivarium in bundling RPM, predictive analytics, and DTx for hospitals and pharma, with a similar focus on continuous monitoring and RWE generation.
• Huma (formerly Medopad): UK-based digital health platform providing RPM, virtual wards, and DTx modules for hospitals and pharma. Comparable to Persei vivarium's integrated hospital-platform-plus-pharma-partnership GTM model, including regulatory-cleared software for decentralized clinical trials.
• Vivify Health: US-based RPM platform offering condition-specific care pathways for chronic disease management, with enterprise deployments to hospitals and payers. Comparable to Persei vivarium's Caaring® and onQos® offerings in targeting hospital-led RPM with a focus on outcomes and adherence.
• Medtep: Barcelona-based digital therapeutics and chronic care platform (now part of Salvat). Comparable to Persei vivarium's Spain-based chronic condition DTx programs in patient pathways, treatment adherence, and provider-pharma partnership models within the Spanish healthcare ecosystem.

Emerging players

• Trialbee: Sweden-based patient recruitment and real-world data platform for clinical trials, with a focus on matching patients to studies using RWE. Comparable to Persei vivarium's registry-driven RWE and patient identification capabilities via ENEIDA-style infrastructure, though Trialbee emphasizes recruitment over disease management.

Broad incumbents

• Medidata Solutions: Global eClinical and clinical data platform owned by Dassault Systèmes, serving the majority of large pharma trials. Comparable to Persei vivarium's ReseaArch® as a clinical research infrastructure provider, though at significantly larger scale and with broader regulatory reach across all trial phases.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/perseivivarium
• LinkedInlinkedin.com/company/perseivivarium
• Instagraminstagram.com/perseivivarium

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries5 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Persei vivarium (Digital Health)